We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of Hepatitis B Vaccination for Adults With Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Authors
Sawyer, Mark H.; Hoerger, Thomas J.; Murphy, Trudy V.; Schillie, Sarah F.; Hu, Dale; Spradling, Philip R.; Byrd, Kathy K.; Jian Xing; Reilly, Meredith L.; Tohme, Rania A.; Moorman, Anne; Smith, Emily A.; Baack, Britney N.; Jiles, Ruth B.; KIevens, Monina; Ward, John W.; Kahn, Henry S.; Fangjun Zhou
- Abstract
The article summarizes the recommendations from the Advisory Committee on Immunication Practices (ACIP) regarding the use of Hepatitis B vaccination for adults with diabetes mellitus. Data from Emerging Infections Program (EIP) sites and the National Health and Nutrition Examination Survey (NHANES) reveal the population risk for Hepatitis B Virus (HBV) infection among adults with diabetes. Hepatitis B vaccines available in the U.S. are the single-antigen recombinant Recombivax HB and Engerix-B vaccines, and the Twinrix hepatitis A and B combination vaccine. The ACIP recommends the administration of Hepatitis B vaccine unvaccinated diabetic adults aged 19-59, while those aged 60 and beyond could be vaccinated at the discretion of the treating clinician.
- Subjects
UNITED States; HEPATITIS B vaccines; DIABETES; PEOPLE with diabetes; HEPATITIS B virus; UNITED States. Advisory Committee on Immunization Practices
- Publication
JAMA: Journal of the American Medical Association, 2012, Vol 307, Issue 7, p659
- ISSN
0098-7484
- Publication type
Article